← Back to Search

Tonometry

iCare ST500 vs GAT and iCare IC200 for Glaucoma

Q: What is the current enrollment figure for this trial?

<p>Affirmative. By referencing clinicaltrials.gov, one can ascertain that this trial is accepting patients. This medical research project was posted on June 5th 2023 and its information has been updated as recently as July 6th 2023 allowing for the recruitment of 150 individuals from a single location.</p>

Q: Are there any vacancies left for participants in this clinical experiment?

<p>As seen on the official clinicaltrials.gov platform, this medical research is presently soliciting participants. This study was first posted to the database on June 5th 2023 and recently updated two days later.</p>

N/A

Waitlist Available

Research Sponsored by Icare Finland Oy

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 4 months

Awards & highlights

Study Summary

This trial showed a new tonometer is reliable to measure eye pressure, a key indicator of glaucoma.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Demonstrate compliance with ANSI Z80.10:2014-Ophthalmics-Ophthalmic Instruments-Tonometers

Trial Design

1Treatment groups

Experimental Treatment

Group I: iCare ST500 vs GAT and iCare IC200Experimental Treatment3 Interventions

Measurement of intraocular pressure (IOP) with iCare ST500 compared to GAT and iCare IC200. Measurements will be performed in three categories: Low IOP (7 to 16 mmHg), Medium IOP (>16 to <23 mmHg), or High IOP (≥23 mmHg).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

GAT

2023

N/A

~170

iCare ST500

2023

N/A

~170

iCare IC200

2023

N/A

~170

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Icare Finland OyLead Sponsor

5 Previous Clinical Trials

589 Total Patients Enrolled

3 Trials studying Glaucoma

229 Patients Enrolled for Glaucoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current enrollment figure for this trial?

"Affirmative. By referencing clinicaltrials.gov, one can ascertain that this trial is accepting patients. This medical research project was posted on June 5th 2023 and its information has been updated as recently as July 6th 2023 allowing for the recruitment of 150 individuals from a single location."

Answered by AI

Are there any vacancies left for participants in this clinical experiment?

"As seen on the official clinicaltrials.gov platform, this medical research is presently soliciting participants. This study was first posted to the database on June 5th 2023 and recently updated two days later."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

iCare ST500 Clinical Trial

2023. "iCare ST500 Clinical Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05742009.